At recurrence, alterations in MGMT methylation status have not been detected [32]; moreover, the relationship with MGMT methylation persists at recurrence, and TMZ re-challenge is a sensible choice for patients with MGMT-methylated GBM [33]. This evidence concerns the gene MGMT and glioblastoma.